From: Cardiovascular disease (CVD): assessment, prediction and policy implications
Years | Original Data | NDGM | Cumulative | RGR | RGR Mean | Dt | Mean Dt |
---|---|---|---|---|---|---|---|
2005 | 857,472 | 857,472 | 857,472 | Â | Â | Â | Â |
2006 | 842,430 | 817,100 | 1,699,903 | 0.684 | 0.228 | 1.072 | 2.514 |
2007 | 827,191 | 817,591 | 2,527,094 | 0.528 | Â | 1.618 | Â |
2008 | 823,970 | 818,325 | 3,351,065 | 0.442 | Â | 1.958 | Â |
2009 | 814,684 | 819,425 | 4,165,749 | 0.219 | Â | 2.216 | Â |
2010 | 805,696 | 821,073 | 4,971,446 | 0.166 | Â | 2.426 | Â |
2011 | 817,311 | 823,541 | 5,788,758 | 0.152 | Â | 2.546 | Â |
2012 | 821,111 | 827,238 | 6,609,869 | 0.135 | Â | 2.713 | Â |
2013 | 830,227 | 832,776 | 7,440,096 | 0.128 | Â | 2.828 | Â |
2014 | 840,356 | 841,071 | 8,280,452 | 0.107 | Â | 2.928 | Â |
2015 | 857,259 | 853,496 | 9,137,711 | 0.089 | Â | 3.145 | Â |
2016 | 880,573 | 872,107 | 10,018,285 | 0.052 | Â | 3.309 | Â |
2017 | 902,270 | 899,984 | 10,920,556 | 0.036 | Â | 3.414 | Â |
2018 | 941,740 | 942,407 | 941,740 | 0.341 | Â | 2.045 | Â |
2019 | 1,004,285 | 101,248 | 1,946,025 | 0.215 | Â | 2.000 | Â |
2020 | Â | 1,097,970 | 3,043,995 | Â | Â | Â | Â |
2021 | Â | 1,238,298 | 4,282,293 | 0.124 | 0.329 | 3.412 | 2.193 |
2022 | Â | 1,448,492 | 5,730,785 | 0.291 | Â | 2.104 | Â |
2023 | Â | 1,763,336 | 7,494,121 | 0.468 | Â | 2.302 | Â |
2024 | Â | 2,234,934 | 9,729,054 | 0.361 | Â | 2.431 | Â |
2025 | Â | 2,441,328 | 12,170,382 | 0.224 | Â | 2.554 | Â |
2026 | Â | 2,999,418 | 15,169,801 | 0.320 | Â | 2.856 | Â |
2027 | Â | 3,050,121 | 18,219,922 | 0.383 | Â | 2.935 | Â |
MAPE % | Â | 1.02% | Â | Â | Â | Â | Â |